| NDC Code | 72854-134-66 |
|---|
| Package Description | 180 mL in 1 BOTTLE (72854-134-66) |
|---|
| Product NDC | 72854-134 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Mucinex Fast-max Severe Congestion And Cough Arctic Burst |
|---|
| Proprietary Name Suffix | Maximum Strength |
|---|
| Non-Proprietary Name | Dextromethorphan Hydrobromide, Guaifenesin, And Phenylephrine Hydrochloride |
|---|
| Dosage Form | SOLUTION |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20211027 |
|---|
| End Marketing Date | 20250515 |
|---|
| Marketing Category Name | OTC MONOGRAPH DRUG |
|---|
| Application Number | M012 |
|---|
| Manufacturer | RB Health (US) LLC |
|---|
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
|---|
| Strength | 20; 400; 10 |
|---|
| Strength Unit | mg/20mL; mg/20mL; mg/20mL |
|---|
| Pharmacy Classes | Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC] |
|---|